Moses Lake Pharmacy Recalls Methionine/Choline/Inositol Injectable Solution
Moses Lake Professional Pharmacy is recalling Methionine/Choline/Inositol injectable solution due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or death from infection.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling Methionine/Choline/Inositol injectable solution, 25/50/50 mg/mL, 10 mL syringes. The recall is being conducted because of a lack of assurance of sterility for all sterile human compounded drugs within their expiry date.
The affected product is a prescription-only injectable solution. The recall covers 2 syringes and is distributed nationwide. Specific lot codes associated with the recall include t03192015@20, t06012015@6, t04292015@18, t06192015@16, and t07012015@26.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- METHIONINE/CHOLINE/INOSITOL, injectable Solution, 25/50/50 MG/ML, 10 mL syringes, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- t03192015@20
- t06012015@6
- t04292015@18
- t06192015@16
- t07012015@26
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereRXQ Compounding Recalls MIC Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SeverePartell Specialty Pharmacy Recalls Methionine Injection Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SevereCompounded Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereAxia Pharmaceutical Recalls Methionine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- SevereVitalab Pharmacy Recalls Sterile Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereFDA Recalls Compounded Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-23